Skip to content Skip to sidebar Skip to footer

Newsletter

Nick Sundich

1,216 articles published

Consumer Retail

Where to next for Solomon Lew and Premier Investments? Does it still have the upper hand on Myer?

Premier Investments (ASX:PMV) is one of those companies synonymous with its boss and this company's leader is Solomon Lew. Premier is an investment company that owns the Just Group, which owns half a dozen retail brands including Smiggle, Peter Alexander, Just Jeans, Jay Jays, Portmans, Jacqui E and Dotti. Premier also has a 25%+ stake…

ByNick SundichSeptember 24, 20240Comments

Mining Stocks Penny Stocks Rare Earths Stocks Small Caps Stocks

Axel REE (ASX: AXL) gets ready for the big time

The equity market hasn't been kind to Axel REE (ASX: AXL), which has three high quality rare earths projects in Brazil. The company did its IPO on ASX in late July after raising $13.3m at 20 cents per share. It ended its first day of trading on 23 July at a mere 12.5 cents, such…

ByNick SundichSeptember 23, 20240Comments

Blue Chip Stocks Education Large Caps Mid Cap Stocks

Here are 6 of the longest serving ASX CEOs

One of biggest shocks among large caps this year was news that one the longest serving ASX CEOs, NIB boss Mark Fitzgibbon, was retiring. After almost 22 years in the job, Fitzgibbon revealed to investors in late July that he was standing down, initially at the end of August, but he agreed to stay on…

ByNick SundichSeptember 19, 20240Comments

Blue Chip Stocks General Healthcare Stocks Large Caps

Should you invest in aged care stocks? Here are 4 reasons to consider them, and 4 reasons to avoid them

Should you invest in aged care stocks? There are plenty of things to like about this sector, including government funding, resilience to tough economic times and the growth in demand that will come as the Baby Boomers age. But it is not all. Should you invest in aged care stocks? The Yes case 1. Ageing population…

ByNick SundichSeptember 17, 20240Comments

Education Healthcare Stocks

Here’s what you need to know about the TGA Special Access Scheme and why its a game changer for ASX biotechs

For ASX biotechs wishing to commercialise drugs in Australia, the Therapeutic Goods Administration (TGA) Special Access Scheme is the next best thing to regulatory approval. Therapeutic goods need to be included on the Australian Register of Therapeutic Goods (ARTG), prior to being sold, imported or exported from Australia. However, the Special Access Scheme provides a way…

ByNick SundichSeptember 16, 20240Comments

Healthcare Stocks Mid Cap Stocks News Penny Stocks Small Caps Stocks

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and New Zealand continues to mature in 2024. In spite of a difficult market for small-cap stocks on the ASX, companies are making progress in the clinic and management teams are building on their learnings…

ByNick SundichSeptember 13, 20240Comments

Education

Gearing: What is it and how can companies exploit it to their advantage?

You may hear a company talk about its gearing. Generally only when it has a low level of gearing, of course. But what is gearing, why are ASX-listed companies either under geared or over geared and what is an appropriate level? In this article, we explore these questions. What is gearing? Gearing is a financial leverage technique…

ByNick SundichSeptember 13, 20240Comments

Education

Private Credit: What is it and why has this US$1tn market become such a popular investment option?

Private credit is a US$1 trillion (A$1.49tn) market and $200bn in Australia alone. It is clearly worth knowing about and paying attention to. Stocks Down Under provides a lowdown of what private credit is, and why it has become so popular. What is private credit? Private credit refers to non-bank lending provided by private investment firms…

ByNick SundichSeptember 10, 20240Comments

General Healthcare Stocks Penny Stocks Small Caps Stocks

Invion (ASX:IVX): Using Photodynamic Therapy to fight cancer

Unless you're a professional dermatologist, you may not have ever heard of Photodynamic Therapy, let alone thought of it as an option to fight cancer as Invion (ASX:IVX) is doing. Invion may not appear to be an appealing investment at first glance, given its status as a 'penny stock' with a share price as a fraction…

ByNick SundichSeptember 9, 20240Comments

Agriculture Stocks Penny Stocks Small Caps Stocks Undervalued Stocks

Bio Gene Technology (ASX:BGT): Commercialising a new class of insecticides

Bio Gene Technology (ASX:BGT) ASX-listed AgTech company developing two compounds - Flavocide™ and Qcide™ - as insecticides. Investors may hear the word insecticide and think that Flavocide™ and Qcide™ are just another couple of consumer insect sprays (such as Mortein) and wonder whether the market really needs it. How can Bio Gene's compounds stand out…

ByNick SundichSeptember 9, 20240Comments

the Kick-ass Multipurpose WordPress Theme

Nick Sundich

Where to next for Solomon Lew and Premier Investments? Does it still have the upper hand on Myer?

Axel REE (ASX: AXL) gets ready for the big time

Here are 6 of the longest serving ASX CEOs

Should you invest in aged care stocks? Here are 4 reasons to consider them, and 4 reasons to avoid them

Here’s what you need to know about the TGA Special Access Scheme and why its a game changer for ASX biotechs

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

Gearing: What is it and how can companies exploit it to their advantage?

Private Credit: What is it and why has this US$1tn market become such a popular investment option?

Invion (ASX:IVX): Using Photodynamic Therapy to fight cancer

Bio Gene Technology (ASX:BGT): Commercialising a new class of insecticides

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Nick Sundich

Stocks in Spotlight

Add Your Heading Text Here